Vulnerability in Philips Patient Information Center Ix
CVE-2020-16220
In Patient Information Center iX (PICiX) Versions C.02, C.03, PerformanceBridge Focal Point Version A.01, the product receives input that is expected to be well-formed (i.e., to comply with a certain syntax) but it does not validate or incorrectly validates that the input complies with the syntax, causing the certificate enrollment service to crash. It does not impact monitoring but prevents new devices from enrolling.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L.
EPSS exploit prediction
EPSS: 0.003 (18.4th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 18th percentile — 18.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Philips Patient Information Center Ix — versions b.02, c.02, c.03
- Philips Patient Information Center Ix (Picix) — versions C.02, C.03
- Philips Performancebridge Focal Point — versions A.01
- Philips Performancebridge Focal Point — versions a.01
Weakness classification (CWE)
Public proof-of-concept exploits
References
- us-cert.cisa.gov/ics/advisories/icsma-20-254-01 (US Government Resource, Third Party Advisory)
- www.philips.com/productsecurity
Frequently asked questions
- What is CVE-2020-16220?
- CVE-2020-16220 is a medium-severity vulnerability in Philips Patient Information Center Ix, classified under CWE-1286. CVSS score: 4.3/10. Published 2020-09-11.
- How severe is CVE-2020-16220?
- Medium severity. CVSS v3 base score is 4.3 out of 10.
- Is CVE-2020-16220 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.